SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882104-18-000079
Filing Date
2018-06-25
Accepted
2018-06-25 16:10:28
Documents
2
Period of Report
2018-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_152995741179957.html 3  
1 FORM 3 wf-form3_152995741179957.xml 3 1683
2 POWER OF ATTORNEY: /S/ NATHAN N. KRYSZAK, ATTORNEY-IN-FACT FOR ELIZABETH O'FARRE ex-24.htm EX-24 3652
  Complete submission text file 0000882104-18-000079.txt   6788
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
O'Farrell Elizabeth G. (Reporting) CIK: 0001744662 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 18917156